Mrs Taryn Suzanne Ivie, CADC | |
1320 N 3300 E, Ashton, ID 83420-5018 | |
(208) 589-9054 | |
(208) 624-1351 |
Full Name | Mrs Taryn Suzanne Ivie |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 1320 N 3300 E, Ashton, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124412747 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 10221 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Taryn Suzanne Ivie, CADC 1320 N 3300 E, Ashton, ID 83420-5018 Ph: (208) 589-9054 | Mrs Taryn Suzanne Ivie, CADC 1320 N 3300 E, Ashton, ID 83420-5018 Ph: (208) 589-9054 |
News Archive
A Saint Louis University investigator noted for her pain research is working to reduce a painful chemotherapy side effect, thanks to a $126,500 grant from the Mayday Fund, an organization dedicated to alleviating the incidence, degree and consequence of human physical pain.
Stem cell researchers at UCLA have proven definitively that blood stem cells are made during mid-gestational embryonic development by endothelial cells, the cells that line the inside of blood vessels.
Patients with severe cases of kidney stones are 26 percent less likely to receive timely treatment when they're admitted to the hospital on the weekend, according to a study by researchers at Loyola Medicine and Loyola University Chicago Stritch School of Medicine.
Women with polycystic ovary syndrome, the most common hormone condition among young women, are prone to mental health disorders, and their children face an increased risk of developing attention deficit hyperactivity disorder and autism spectrum disorder, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Results of an all-Canadian study announced June 13 at an international diabetes congress demonstrate that patients with type 2 diabetes can safely achieve target blood sugar (glycemic) levels faster and more frequently when insulin glargine (a basal, long-acting insulin) is added to therapy, versus using oral agents alone.
› Verified 4 days ago